Cefoperazone Sodium/Sulbactam Sodium

头孢哌酮钠/舒巴坦钠

Report date: 2026/04/21 20:00:18

Base Information

Drug NameCefoperazone Sodium/Sulbactam Sodium
Drug Alias Name舒巴坦钠头孢哌酮钠Sulbactam /CefoperazoneCefoperazone Sodium/Sulbactam头孢哌酮钠●舒巴坦钠头孢哌酮钠和舒巴坦钠 +[16] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics
Mechanisms of ActionBeta Lactamase inhibitorsCell wall inhibitorsBacterial penicillin-binding protein inhibitors
TargetsBeta LactamaseBacterial penicillin-binding protein
Therapy Area/IndicationsUrinary Tract InfectionsRespiratory Tract InfectionsCommunicable Diseases +[4] 
Global Approved IndicationsCommunicable DiseasesBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryJapan
Original Approved Date1986/04/30
Country/TerritoryMainland ChinaJapan
CombinationsYes Cefoperazone SodiumSulbactam sodium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncZhongshan Branch of Zhuhai United Laboratories Co LtdWelman (Xiang Bei) Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsUrinary Tract InfectionsRespiratory Tract InfectionsCommunicable Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeJ01DD62
Related LinksWikipediaKEGG